A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
for
Glioblastoma Multiforme, Astrocytoma, Grade III
Location: Houston TX
Sponsor: David Baskin MD
Sex: All
Age: 18+
Code: NCT03596086
Phase1, Phase2, Recruiting
A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
for
High Grade Glioma, Glioblastoma
Location: Chandler AZ, Phoenix AZ
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Sex: All
Age: 18+
Code: NCT06072586
Early_phase1, Recruiting
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
for
Glioblastoma, Gliosarcoma
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06934889
Phase1, Recruiting
MRI Predictors of Response to Tumor Treating Fields
for
Glioblastoma Multiforme
Location: Brooklyn NY
Sponsor: New York Presbyterian Brooklyn Methodist Hospital
Sex: All
Age: 18+
Code: NCT03642080
Recruiting
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
for
Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06810544
Phase1, Phase2, Recruiting
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM